115 related articles for article (PubMed ID: 7702225)
1. Screening surgeons for HIV infection. A cost-effectiveness analysis.
Owens DK; Harris RA; Scott PM; Nease RF
Ann Intern Med; 1995 May; 122(9):641-52. PubMed ID: 7702225
[TBL] [Abstract][Full Text] [Related]
2. Screening surgeons for HIV infection: assessment of a potential public health program.
Schulman KA; McDonald RC; Lynn LA; Frank I; Christakis NA; Schwartz JS
Infect Control Hosp Epidemiol; 1994 Mar; 15(3):147-55. PubMed ID: 8207171
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of HIV screening in acute care settings.
Owens DK; Nease RF; Harris RA
Arch Intern Med; 1996 Feb; 156(4):394-404. PubMed ID: 8607724
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
Immergluck LC; Cull WL; Schwartz A; Elstein AS
Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of HIV testing of physicians and dentists in the United States.
Phillips KA; Lowe RA; Kahn JG; Lurie P; Avins AL; Ciccarone D
JAMA; 1994 Mar; 271(11):851-8. PubMed ID: 8114240
[TBL] [Abstract][Full Text] [Related]
6. HIV screening of surgeons and dentists: a cost-effectiveness analysis.
Sell RL; Jovell AJ; Siegel JE
Infect Control Hosp Epidemiol; 1994 Oct; 15(10):635-45. PubMed ID: 7844334
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
Sanders GD; Bayoumi AM; Sundaram V; Bilir SP; Neukermans CP; Rydzak CE; Douglass LR; Lazzeroni LC; Holodniy M; Owens DK
N Engl J Med; 2005 Feb; 352(6):570-85. PubMed ID: 15703422
[TBL] [Abstract][Full Text] [Related]
8. How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings.
Farnham PG; Sansom SL; Hutchinson AB
Med Decis Making; 2012; 32(3):459-69. PubMed ID: 22247422
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department.
Dowdy DW; Rodriguez RM; Hare CB; Kaplan B
Acad Emerg Med; 2011 Jul; 18(7):745-53. PubMed ID: 21762236
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
[TBL] [Abstract][Full Text] [Related]
11. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
[TBL] [Abstract][Full Text] [Related]
12. Benefits of HIV screening of blood transfusions in Zambia.
Foster S; Buvé A
Lancet; 1995 Jul; 346(8969):225-7. PubMed ID: 7616804
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India.
Venkatesh KK; Becker JE; Kumarasamy N; Nakamura YM; Mayer KH; Losina E; Swaminathan S; Flanigan TP; Walensky RP; Freedberg KA
PLoS One; 2013; 8(5):e64604. PubMed ID: 23741348
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of screening health care workers for HIV.
Chavey WE; Cantor SB; Clover RD; Reinarz JA; Spann SJ
J Fam Pract; 1994 Mar; 38(3):249-57. PubMed ID: 8126405
[TBL] [Abstract][Full Text] [Related]
15. Potential cost of screening surgeons for HIV.
Roizen MF; Foss J; Mantha S
JAMA; 1994 Aug; 272(6):434-5. PubMed ID: 8040976
[No Abstract] [Full Text] [Related]
16. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
[TBL] [Abstract][Full Text] [Related]
17. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
Wilkinson D; Floyd K; Gilks CF
S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
[TBL] [Abstract][Full Text] [Related]
18. Who should be screened for HIV infection? A cost-effectiveness analysis.
McCarthy BD; Wong JB; Muñoz A; Sonnenberg FA
Arch Intern Med; 1993 May; 153(9):1107-16. PubMed ID: 8481077
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
[TBL] [Abstract][Full Text] [Related]
20. Screening for human immunodeficiency virus in physicians. Who should we test and what will it cost.
Levine AA; Sandler RS
N C Med J; 1994 Apr; 55(4):136-40. PubMed ID: 8008080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
